0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Tuberculosis Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-26S5910
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Tuberculosis Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Tuberculosis Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-26S5910
Report
September 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tuberculosis Testing - Market Size

The global market for Tuberculosis Testing was estimated to be worth US$ 2466.8 million in 2023 and is forecast to a readjusted size of US$ 2878.6 million by 2030 with a CAGR of 2.2% during the forecast period 2024-2030

Tuberculosis Testing - Market

Tuberculosis Testing - Market

Tuberculosis is a highly infectious bacterial infection, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. Tuberculosis (TB) can be caught by breathing in air that an infected person has contaminated through: Breathing, coughing. Furthermore, the disease is ranked second leading cause of death, after human immunodeficiency virus (HIV). Individual majorly suffer from two predominant forms of TB: Active tuberculosis and Latent tuberculosis. The global tuberculosis testing market comprises diagnostic tests, equipment’s and testing procedures that contribute assistance in diagnostic of tuberculosis infection.
North American market for Tuberculosis Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tuberculosis Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Tuberculosis Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Tuberculosis Testing include Abbott Laboratories, Akonni Biosystems, Abbott, Becton, Dickinson and Company, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Thermo Fischer Scientific and bioMérieux SA, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tuberculosis Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Tuberculosis Testing by region & country, by Type, and by Application.
The Tuberculosis Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Testing.
Market Segmentation

Scope of Tuberculosis Testing - Market Report

Report Metric Details
Report Name Tuberculosis Testing - Market
Forecasted market size in 2030 US$ 2878.6 million
CAGR 2.2%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Hospitals
  • Laboratories
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Akonni Biosystems, Abbott, Becton, Dickinson and Company, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Thermo Fischer Scientific, bioMérieux SA, Siemens Healthineer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Tuberculosis Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Tuberculosis Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Tuberculosis Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Tuberculosis Testing - Market size in 2030?

Ans: The Tuberculosis Testing - Market size in 2030 will be US$ 2878.6 million.

Who are the main players in the Tuberculosis Testing - Market report?

Ans: The main players in the Tuberculosis Testing - Market are Abbott Laboratories, Akonni Biosystems, Abbott, Becton, Dickinson and Company, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Thermo Fischer Scientific, bioMérieux SA, Siemens Healthineer

What are the Application segmentation covered in the Tuberculosis Testing - Market report?

Ans: The Applications covered in the Tuberculosis Testing - Market report are Hospitals, Laboratories, Others

What are the Type segmentation covered in the Tuberculosis Testing - Market report?

Ans: The Types covered in the Tuberculosis Testing - Market report are Smear Microscopy, Nucleic Acid Testing, Radiography, Culture Based Tests, Drug Susceptibility Testing, Others

Recommended Reports

Tuberculosis Diagnostics

Infectious Disease Testing

Blood and Laboratory Testing

1 Market Overview
1.1 Tuberculosis Testing Product Introduction
1.2 Global Tuberculosis Testing Market Size Forecast
1.3 Tuberculosis Testing Market Trends & Drivers
1.3.1 Tuberculosis Testing Industry Trends
1.3.2 Tuberculosis Testing Market Drivers & Opportunity
1.3.3 Tuberculosis Testing Market Challenges
1.3.4 Tuberculosis Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tuberculosis Testing Players Revenue Ranking (2023)
2.2 Global Tuberculosis Testing Revenue by Company (2019-2024)
2.3 Key Companies Tuberculosis Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Tuberculosis Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Tuberculosis Testing
2.6 Tuberculosis Testing Market Competitive Analysis
2.6.1 Tuberculosis Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Tuberculosis Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Smear Microscopy
3.1.2 Nucleic Acid Testing
3.1.3 Radiography
3.1.4 Culture Based Tests
3.1.5 Drug Susceptibility Testing
3.1.6 Others
3.2 Global Tuberculosis Testing Sales Value by Type
3.2.1 Global Tuberculosis Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tuberculosis Testing Sales Value, by Type (2019-2030)
3.2.3 Global Tuberculosis Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Laboratories
4.1.3 Others
4.2 Global Tuberculosis Testing Sales Value by Application
4.2.1 Global Tuberculosis Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tuberculosis Testing Sales Value, by Application (2019-2030)
4.2.3 Global Tuberculosis Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Tuberculosis Testing Sales Value by Region
5.1.1 Global Tuberculosis Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tuberculosis Testing Sales Value by Region (2019-2024)
5.1.3 Global Tuberculosis Testing Sales Value by Region (2025-2030)
5.1.4 Global Tuberculosis Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Tuberculosis Testing Sales Value, 2019-2030
5.2.2 North America Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Tuberculosis Testing Sales Value, 2019-2030
5.3.2 Europe Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Tuberculosis Testing Sales Value, 2019-2030
5.5.2 South America Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Tuberculosis Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tuberculosis Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tuberculosis Testing Sales Value
6.3 United States
6.3.1 United States Tuberculosis Testing Sales Value, 2019-2030
6.3.2 United States Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tuberculosis Testing Sales Value, 2019-2030
6.4.2 Europe Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tuberculosis Testing Sales Value, 2019-2030
6.5.2 China Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tuberculosis Testing Sales Value, 2019-2030
6.6.2 Japan Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tuberculosis Testing Sales Value, 2019-2030
6.7.2 South Korea Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tuberculosis Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tuberculosis Testing Sales Value, 2019-2030
6.9.2 India Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tuberculosis Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Tuberculosis Testing Products, Services and Solutions
7.1.4 Abbott Laboratories Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Akonni Biosystems
7.2.1 Akonni Biosystems Profile
7.2.2 Akonni Biosystems Main Business
7.2.3 Akonni Biosystems Tuberculosis Testing Products, Services and Solutions
7.2.4 Akonni Biosystems Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Akonni Biosystems Recent Developments
7.3 Abbott
7.3.1 Abbott Profile
7.3.2 Abbott Main Business
7.3.3 Abbott Tuberculosis Testing Products, Services and Solutions
7.3.4 Abbott Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Becton, Dickinson and Company Recent Developments
7.4 Becton, Dickinson and Company
7.4.1 Becton, Dickinson and Company Profile
7.4.2 Becton, Dickinson and Company Main Business
7.4.3 Becton, Dickinson and Company Tuberculosis Testing Products, Services and Solutions
7.4.4 Becton, Dickinson and Company Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Becton, Dickinson and Company Recent Developments
7.5 Cepheid
7.5.1 Cepheid Profile
7.5.2 Cepheid Main Business
7.5.3 Cepheid Tuberculosis Testing Products, Services and Solutions
7.5.4 Cepheid Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Cepheid Recent Developments
7.6 Epistem Holdings Plc
7.6.1 Epistem Holdings Plc Profile
7.6.2 Epistem Holdings Plc Main Business
7.6.3 Epistem Holdings Plc Tuberculosis Testing Products, Services and Solutions
7.6.4 Epistem Holdings Plc Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Epistem Holdings Plc Recent Developments
7.7 F. Hoffmann-La Roche AG
7.7.1 F. Hoffmann-La Roche AG Profile
7.7.2 F. Hoffmann-La Roche AG Main Business
7.7.3 F. Hoffmann-La Roche AG Tuberculosis Testing Products, Services and Solutions
7.7.4 F. Hoffmann-La Roche AG Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.7.5 F. Hoffmann-La Roche AG Recent Developments
7.8 Thermo Fischer Scientific
7.8.1 Thermo Fischer Scientific Profile
7.8.2 Thermo Fischer Scientific Main Business
7.8.3 Thermo Fischer Scientific Tuberculosis Testing Products, Services and Solutions
7.8.4 Thermo Fischer Scientific Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Thermo Fischer Scientific Recent Developments
7.9 bioMérieux SA
7.9.1 bioMérieux SA Profile
7.9.2 bioMérieux SA Main Business
7.9.3 bioMérieux SA Tuberculosis Testing Products, Services and Solutions
7.9.4 bioMérieux SA Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.9.5 bioMérieux SA Recent Developments
7.10 Siemens Healthineer
7.10.1 Siemens Healthineer Profile
7.10.2 Siemens Healthineer Main Business
7.10.3 Siemens Healthineer Tuberculosis Testing Products, Services and Solutions
7.10.4 Siemens Healthineer Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Siemens Healthineer Recent Developments
8 Industry Chain Analysis
8.1 Tuberculosis Testing Industrial Chain
8.2 Tuberculosis Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tuberculosis Testing Sales Model
8.5.2 Sales Channel
8.5.3 Tuberculosis Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Tuberculosis Testing Market Trends
    Table 2. Tuberculosis Testing Market Drivers & Opportunity
    Table 3. Tuberculosis Testing Market Challenges
    Table 4. Tuberculosis Testing Market Restraints
    Table 5. Global Tuberculosis Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Tuberculosis Testing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Tuberculosis Testing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Tuberculosis Testing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Tuberculosis Testing
    Table 10. Global Tuberculosis Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Testing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Tuberculosis Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Tuberculosis Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Tuberculosis Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Tuberculosis Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Tuberculosis Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Tuberculosis Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Tuberculosis Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Tuberculosis Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Tuberculosis Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Tuberculosis Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Tuberculosis Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Tuberculosis Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Tuberculosis Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Tuberculosis Testing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Tuberculosis Testing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Tuberculosis Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Tuberculosis Testing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Tuberculosis Testing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Laboratories Basic Information List
    Table 32. Abbott Laboratories Description and Business Overview
    Table 33. Abbott Laboratories Tuberculosis Testing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Tuberculosis Testing Business of Abbott Laboratories (2019-2024)
    Table 35. Abbott Laboratories Recent Developments
    Table 36. Akonni Biosystems Basic Information List
    Table 37. Akonni Biosystems Description and Business Overview
    Table 38. Akonni Biosystems Tuberculosis Testing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Tuberculosis Testing Business of Akonni Biosystems (2019-2024)
    Table 40. Akonni Biosystems Recent Developments
    Table 41. Abbott Basic Information List
    Table 42. Abbott Description and Business Overview
    Table 43. Abbott Tuberculosis Testing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Tuberculosis Testing Business of Abbott (2019-2024)
    Table 45. Abbott Recent Developments
    Table 46. Becton, Dickinson and Company Basic Information List
    Table 47. Becton, Dickinson and Company Description and Business Overview
    Table 48. Becton, Dickinson and Company Tuberculosis Testing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Tuberculosis Testing Business of Becton, Dickinson and Company (2019-2024)
    Table 50. Becton, Dickinson and Company Recent Developments
    Table 51. Cepheid Basic Information List
    Table 52. Cepheid Description and Business Overview
    Table 53. Cepheid Tuberculosis Testing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Tuberculosis Testing Business of Cepheid (2019-2024)
    Table 55. Cepheid Recent Developments
    Table 56. Epistem Holdings Plc Basic Information List
    Table 57. Epistem Holdings Plc Description and Business Overview
    Table 58. Epistem Holdings Plc Tuberculosis Testing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Tuberculosis Testing Business of Epistem Holdings Plc (2019-2024)
    Table 60. Epistem Holdings Plc Recent Developments
    Table 61. F. Hoffmann-La Roche AG Basic Information List
    Table 62. F. Hoffmann-La Roche AG Description and Business Overview
    Table 63. F. Hoffmann-La Roche AG Tuberculosis Testing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Tuberculosis Testing Business of F. Hoffmann-La Roche AG (2019-2024)
    Table 65. F. Hoffmann-La Roche AG Recent Developments
    Table 66. Thermo Fischer Scientific Basic Information List
    Table 67. Thermo Fischer Scientific Description and Business Overview
    Table 68. Thermo Fischer Scientific Tuberculosis Testing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Tuberculosis Testing Business of Thermo Fischer Scientific (2019-2024)
    Table 70. Thermo Fischer Scientific Recent Developments
    Table 71. bioMérieux SA Basic Information List
    Table 72. bioMérieux SA Description and Business Overview
    Table 73. bioMérieux SA Tuberculosis Testing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Tuberculosis Testing Business of bioMérieux SA (2019-2024)
    Table 75. bioMérieux SA Recent Developments
    Table 76. Siemens Healthineer Basic Information List
    Table 77. Siemens Healthineer Description and Business Overview
    Table 78. Siemens Healthineer Tuberculosis Testing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Tuberculosis Testing Business of Siemens Healthineer (2019-2024)
    Table 80. Siemens Healthineer Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Tuberculosis Testing Downstream Customers
    Table 84. Tuberculosis Testing Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Tuberculosis Testing Product Picture
    Figure 2. Global Tuberculosis Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Tuberculosis Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Tuberculosis Testing Report Years Considered
    Figure 5. Global Tuberculosis Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuberculosis Testing Revenue in 2023
    Figure 7. Tuberculosis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Smear Microscopy Picture
    Figure 9. Nucleic Acid Testing Picture
    Figure 10. Radiography Picture
    Figure 11. Culture Based Tests Picture
    Figure 12. Drug Susceptibility Testing Picture
    Figure 13. Others Picture
    Figure 14. Global Tuberculosis Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Tuberculosis Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Laboratories
    Figure 18. Product Picture of Others
    Figure 19. Global Tuberculosis Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Tuberculosis Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Tuberculosis Testing Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Tuberculosis Testing Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Tuberculosis Testing Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Tuberculosis Testing Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Tuberculosis Testing Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Tuberculosis Testing Sales Value (%), (2019-2030)
    Figure 32. United States Tuberculosis Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Tuberculosis Testing Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Tuberculosis Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Tuberculosis Testing Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Tuberculosis Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Tuberculosis Testing Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Tuberculosis Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Tuberculosis Testing Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Tuberculosis Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Tuberculosis Testing Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Tuberculosis Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Tuberculosis Testing Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Tuberculosis Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Tuberculosis Testing Sales Value by Application (%), 2023 VS 2030
    Figure 53. Tuberculosis Testing Industrial Chain
    Figure 54. Tuberculosis Testing Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS